Melissa McBurnie
Président chez MetabloQ Pty Ltd.
Profil
Melissa McBurnie is currently the Chairman at MetabloQ Pty Ltd.
and the Director at Ankere Therapeutics.
She is also a Partner at Brandon Capital Partners Pty Ltd.
Dr. McBurnie has a graduate degree from the University of Adelaide and an MBA from the same institution.
Postes actifs de Melissa McBurnie
| Sociétés | Poste | Début |
|---|---|---|
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Private Equity Investor | 01/01/2008 |
MetabloQ Pty Ltd.
 MetabloQ Pty Ltd. BiotechnologyHealth Technology MetabloQ Pty Ltd. develops drugs for cancer treatment. It treats triple-negative breast cancer, prostate cancer and melanoma cancer diseases. The company was founded in 2016 and is headquartered in Melbourne, Australia. | Président | - |
Ankere Therapeutics
 Ankere Therapeutics BiotechnologyHealth Technology Ankere Therapeutics develops therapeutics for inflammatory diseases. The Australian company was founded by Stuart Pitson, Bernard Flynn. Bernard Flynn has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Formation de Melissa McBurnie
| University of Adelaide | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
MetabloQ Pty Ltd.
MetabloQ Pty Ltd. BiotechnologyHealth Technology MetabloQ Pty Ltd. develops drugs for cancer treatment. It treats triple-negative breast cancer, prostate cancer and melanoma cancer diseases. The company was founded in 2016 and is headquartered in Melbourne, Australia. | Health Technology |
Ankere Therapeutics
Ankere Therapeutics BiotechnologyHealth Technology Ankere Therapeutics develops therapeutics for inflammatory diseases. The Australian company was founded by Stuart Pitson, Bernard Flynn. Bernard Flynn has been the CEO since incorporation. | Health Technology |
